Abstract Submission 

 

THE CALL FOR ABSTRACTS WILL OPEN ON JULY 1, 2022


IMPORTANT DATES

Call for Abstracts - July 1, 2022
Deadline for Call for abstract - October 15, 2022
Deadline for Abstracts evaluation - November 8, 2022
Notification to Authors - By November 28, 2022
Presenter’s registration to the congress - December 8, 2022
 

TOPICS

HIP
DDH
SPINE
LOWER LIMB DEFORMITY
FOOT
NEUROMUSCULAR
CONGENITAL, SYNDROMES, SKELETAL DYSPLASIAS
TRAUMA
UPPER EXTREMITY
INFECTION
TUMOURS
SPORTS
MISCELLANEOUS
BASIC SCIENCE
 

GUIDELINES FOR ABSTRACT SUBMISSION

Please carefully review the following guidelines prior to submitting an abstract:

Type of Presentation

Abstracts may be presented as oral or  e-poster.

Abstract topics

When uploading the abstract, please select one of the following topics:
HIP
DDH
SPINE
LOWER LIMB DEFORMITY
FOOT
NEUROMUSCULAR
CONGENITAL, SYNDROMES, SKELETAL DYSPLASIAS
TRAUMA
UPPER EXTREMITY
INFECTION
TUMOURS
SPORTS
MISCELLANEOUS
BASIC SCIENCE
 

Level of Evidence

Please indicate the Level of Evidence in the drop-down menu indication level I – VII.
The EPOS Reading Committee may change the Level of Evidence if deemed necessary. For more info: here


Preparation of abstracts

Submission title:
1.    The title should be as brief as possible but long enough to clearly indicate the nature of the study.
2.    No identifying features such as names of authors, hospitals, medical schools, clinics, or cities may be listed in the title or abstract text, as a “blind” review process will be used.
3.    Capitalize the first letter of trade names

Note: Do not use capital letters

Author / Authors
Authors should be introduced in the order in which they will be included in the published abstract.
For each author please provide:
•    First name
•    Last name
•    Institution / affiliation ( only department name,  institution/company name, do not include any address)
•    City
•    Country

Note: Please do not use capital letters

Abstract content:
1.    Abstracts should be clear, concise, and written and presented in English. Abstracts will be  published as submitted. Presenters are requested to carefully proofread their abstract.
2.    The abstract word limit is max. 300 words per abstract.
3.    Abstracts must include the following sections:
•    Introduction and Objective (Clearly state the purpose of the abstract)
•    Materials and Methods (Describe your selection of observations or experimental subjects clearly)
•    Results (Present your results in a logical sequence in text, table, and illustrations)
•    Conclusions (Emphasize new and important aspects of the study and the conclusions that are drawn from them)
4.    Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
5.    All abbreviations must be defined in first use.
6.    Use of brand names: Generic names must be used for all references to products or companies. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e., not in a reference at the bottom of the page) may be rejected for this reason only. EPOS reserves the right to replace any brand name with a generic name without further notice.
7.    Please do not include references, credits or grant suport

Note: Do not use capital letters

Tables and Figures:
Tables and figues should be included as attachents but their exact location should be indicated in the body of the abstract by entering the name of the table and/or graph.
Figures should be attached as a jpg or png format, maximum file size: 10 MB (Attachment 1 - Figures)
Tables should be attached  as Microsoft Word (doc, docx, odt) or Microsoft Excel (xls, xlsx, ods) format, maximum file size: 10 MB (Attachment 2 – Tables)

Note: Do not use capital letters
 

More information

The EPOS Annual meeting welcomes papers as Oral Presentations and E-posters. Authors may submit multiple papers as E-posters.
 
There is no limitation as far as number of submissions are concerned for all categories.
However, in Oral (podium) category only two abstracts as a first author will be accepted.
In case the same author is involved in additional papers, the author must appear as co-author on these papers.
No last minute change of the presenting author will be acceptable without written proof for the reason for absence. An author who have two podium abstracts accepted may not substitute an-other presenter.
In order to present their Oral / E-Poster authors/presenters shall be regularly registered to the congress


w
w
w